Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SKF completes acquisition of Tenute Srl

Gothenburg, 9 November 2022: SKF has completed the previously announced acquisition of Tenute Srl. Tenute develops and manufactures sealing solutions for various industrial applications and has approximately 50 employees. Tenute Srl will be integrated into SKF’s existing Seals business. Peter Thorpman, Director, SKF Seals, says: “We’re glad to welcome our new colleagues to SKF. This acquisition strengthens our already leading offer, with a particular focus on customers in heavy and process industries.” Aktiebolaget SKF      (publ)

Swedish Stirling obtains conversion undertakings of MSEK 50 from KV4 convertible bond holders

Swedish Stirling AB (publ) (“Swedish Stirling” or the “Company”) has obtained irrevocable undertakings from holders of convertible bonds 2020/2025 (“KV4”) regarding conversion into ordinary shares of MSEK 50 of the loan amount, consent to the proposed amendments of the terms and conditions of KV4 and lock-up on shares that result from conversion.Swedish Stirling has reached an agreement with all holders of KV4 according to which the Company has received irrevocable undertakings from the convertible bond holders to convert 50 per cent of the total outstanding loan amount under KV4,

Norse Atlantic Airways releases first routes of summer 2023 schedule

From today customers can book on Norse Atlantic to travel in summer 2023 as the first stage of flights are released for sale. Popular routes between Europe and New York, Fort Lauderdale and Los Angeles are now available through to October 2023.Further new routes and destinations for the summer will be announced in December and early 2023 providing customers with greater choice at an affordable price. The initial summer schedule, which operates between March and October 2023, includes: From OSLO · Oslo to New York JFK, three times a week, from NOK 2299 one way in economy including

Hexagon Agility receives new order from Xpress Natural Gas (XNG) for Mobile Pipeline® modules to meet customer demand for clean energy

9 November 2022: Hexagon Agility, a business of Hexagon Composites, received a new order from Xpress Natural Gas LLC (XNG), a leading full-service provider of compressed natural gas (CNG) in the United States, to deliver Mobile Pipeline[®] modules to transport clean and renewable natural gas (RNG).   This order has an estimated value of USD 14.8 million (approx. NOK 150 million). Delivering safe and innovative solutions “We look forward to continuing to grow our relationship with Hexagon Agility as a key supplier to XNG as we work to provide safe, reliable cleaner energy solutions

DIF Capital Partners invests €150 million in Alight

DIF Capital Partners will acquire a majority stake in Stockholm-headquartered Alight, a leading developer of subsidy-free solar projects in the Nordics. The agreement includes an investment of EUR 150 million and a secondary buy-out of a number of existing shareholders. With the capital raised, Alight will accelerate the buildout of its near term pipeline of solar projects.The company will do so by building out and retaining ownership of projects going forward and aiding the transition into an independent power producer. Alight built its foundation in the Nordic solar market by offering

Siemens Healthineers to demonstrate capabilities of Corindus CorPath GRX Robotic System using Mentice VIST ® Simulator

Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is showcasing the capabilities of the Corindus CorPath GRX Robotic PCI system by using the Mentice VIST ® Virtual Patient simulator. This year’s China International Import Expo (CIIE 2022) will be the first event to showcase the CorPath GRX Robotic System and Mentice VIST ® Virtual Patient integration. The VIST ® Virtual Patient simulator enables Siemens Healthineers to demonstrate the unique capabilities of the CorPath GRX Robotic System effectively

Impero releases 2022-Q3 Report: Realizes DKK 21.4M in Annual Recurring Revenue corresponding to 39% growth compared to 30 September 2021

Company Announcement No. 9-2022 Copenhagen, 9 November 2022 At the end of the third quarter of 2022, Impero realizes a 39% year-on-year Annual Recurring Revenue (ARR) growth rate and continues to demonstrate solid SaaS metrics. Impero maintains guidance for the full year of 2022, and as communicated in connection with 2022-H1, we expect that fulfillment of the ARR guidance likely is at the lower level of the DKK 26-29M range. Further, EBITDA is expected to be at the better level within the DKK -22 to -18M range. Financial highlights on 30 September 2022 · ARR increased by 39%

Veg of Lund AB: Interim Report January - September 2022

July–September 2022    •    Net sales amounted to TSEK 349 (610).•    Operating profit before depreciation and amortization (EBITDA) amounted to TSEK -5,143 (-5,933), and EBIT amounted to TSEK -5,195 (-6,061).•    Net profit amounted to TSEK -5,446 (-6,178). January–September 2022•    Net sales amounted to TSEK 1,873 (1,269).•    Operating profit before depreciation and amortization (EBITDA) amounted to TSEK -34,147 (-13,513), and EBIT amounted to TSEK -34,302 (-13,875).•    Net profit amounted to TSEK -34,628 (-14,035). Significant events July–September 2022•    The

BioStock: Saniona ready for phase I with SAN903

Saniona has finalised preclinical studies with its anti inflammatory and anti-fibrotic drug candidate SAN903. According to the company, compelling data indicates that the candidate has the potential to become a first-line treatment in patients suffering from inflammatory bowel disease. BioStock got in touch with Saniona’s CEO and co-founder Thomas Feldthus to learn more.Read the full interview with Saniona's CEO Thomas Feldthus at biostock.se: https://www.biostock.se/en/2022/11/saniona-ready-for-phase-i-with-san903/ This is a press release from BioStock - Connecting Innovation &

Vestas secures 300 MW order of EnVentus turbines for Goose Creek Wind in the USA

News release from Vestas-American Wind TechnologyPortland, 9 November 2022 Vestas has received a 300 MW order from Apex Clean Energy to power the Goose Creek Wind project in Illinois, USA. The order consists of 50 V162-6.2 MW turbines delivered in 6.0 MW operating mode. The order includes supply, delivery, and commissioning of the turbines, as well as a 10-year Active Output Management 5000 (AOM 5000) service agreement, designed to ensure optimised performance of the asset. “Our advanced modularised design in the EnVentus platform enables our customers to expand their wind energy

Interim Report Q3 2022: New clients contribute to continued strong organic growth

Company Announcement no. 15/20229 November 2022   Wirtek’s Board of Directors has today approved the interim report for Q3 2022. Below a summary - the detailed report is attached to this announcement. CEO Michael Aaen comments: “We are looking back on yet another quarter with strong organic revenue growth of 21% compared to Q3 2021 and EBITDA grew by 2%. The implementation of the new ERP system, the conversion to IFRS and the introduction of a new modern hybrid organization are all being executed satisfactorily, and we are satisfied with the financial results. During the

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

Oblique Therapeutics is delighted to announce the appointment of Christer Nordstedt M.D. PhD . as Chief Executive Officer.

Gothenburg, Sweden,9 November 2022 – Oblique Therapeutics AB (publ.), a biotechnology company focused on new antibody medicines for severe diseases with large unmet medical needs, is pleased to announce the confirmation of Christer Nordstedt MD.PhD. as Chief Executive Officer (CEO). Christer Nordstedt will assume the position on 1[st] December 2022.Christer Nordstedt has abroad and extensive international experience within the pharmaceutical industry from operational and strategic positions at management level in companies like Vivesto, Teva Pharmaceuticals, Orion Corporation, Eli Lilly,

Gapwaves publishes Interim Report for July - September 2022

Strong net sales growthThird quarter: 1 July – 30 September 2022 (Parent company)  · Net sales amounted to MSEK 30.9 (MSEK 8.5)   · EBITDA amounted to MSEK 6.3 (MSEK –7.9)   · Net result amounted to MSEK 5.9 (MSEK –9.2) corresponding to SEK 0.19 (SEK -0.30) per share   · Cash flow for the period was MSEK –4.3 (MSEK –12.4) and cash and cash equivalents at the end of the period amounted to MSEK 178 During Q3, the net sales revenue was MSEK 30.9, a growth of 261% compared to the same period in 2021. The revenue was MSEK 53 year-to-date. Q3 was a profitable quarter, with an

Q3 Update: Trophy Games increases YoY revenue with 24% and YoY EBITDA with 191%

Company Announcement No. 10-2022 Copenhagen, 9 November 2022   Highlights Q3 · Group revenue Q3 2022 was DKK 12.1m, which is 24% higher than Q3 2021. · Group EBITDA Q3 2022 was DKK 2.0m, which is 191% higher than Q3 2021. · Unique paying users total Q3 2022 was 43,454, which is 20% higher than Q3 2021. · Total transactions Q3 2022 was 143,891, which is 15% higher than Q3 2021. · Total installs Q3 2022 was 1.8m, which is 22% higher than Q3 2021. Year to date · Group revenue YTD 2022 was DKK 38.1m, which is 37% higher than the same period in 2021. ·

Betsson AB's Nomination Committee for the Annual General Meeting 2023

The Nomination Committee of Betsson AB (publ) for the Annual General Meeting 2023 has been appointed based on the ownership structure as of 31 August 2022.   The Nomination Committee consists of: Jenny Rosberg, appointed by Hamberg Förvaltning AB Mats Axell, appointed by Knutsson Holdings AB Karin Källström, appointed by Berit Lindwall   The Annual General Meeting 2023 of Betsson AB will be held on Wednesday, 10 May 2023.   Shareholders who would like to make proposals to the Nomination Committee may do so by email to info@betssonab.com or by post to Betsson AB,

Unibet signs partnership with Dutch cycling team Tour de Tietema

Unibet signs a partnership with Dutch cycling team Tour de Tietema. As of 1 January 2023, Kindred’s flagship brand Unibet will be the main sponsor of TDT-Unibet Cycling Team. The new team will start on the continental level but has the ambition to achieve the ProTeam status in the future.Kindred Group plc (Kindred) and its flagship brand Unibet enters a commercial partnership with Tour de Tietema in the Netherlands and Belgium. In addition to a commercial partnership, Tour de Tietema and Unibet will work together to inspire sports enthusiasts to start cycling themselves. Increasing social

Episurf Medical invites to a Capital Markets Day, November 16, 2022

EPISURF MEDICAL AB invites investors, analysts and media to a Capital Markets Day in Stockholm on Wednesday, November 16, 2022 at 13.00-16.00. Presentations will be held by members of Episurf Medical’s management group and customers, focusing on the company’s global commercial opportunities and strategy for the coming years. Presenters will be CEO Pål Ryfors, COO Katarina Flodström, President of Episurf Medical Inc. Patrick Jamnik, and Head of Sales OUS Stephen Caswell. They will be joined by Associate Professor Tim Spalding who is involved in studies on the Episealer® technology, and

TF Bank: Monthly statistics October 2022

The total loan portfolio amounted to SEK 13,938 million at the end of October. Compared to October 2021, the loan portfolio has increased by 28 % in local currencies.  Month Oct-22 Oct-21 ChangeConsumer Lending   New lending, SEK million 506 446 13 %Credit Cards   New lending, SEK million 566 242 134 %Ecommerce Solutions   Transaction volume*, SEK million 881 735 20 %  Cumulative for the year Jan-Oct 22 Jan-Oct 21 ChangeConsumer Lending   New lending, SEK million

Strong interest in Ortoma's new 3D modelling concept

Ortoma AB (publ) (”Ortoma” or the ”Company”) today announces that the Company's proof-of-concept presentations of the new technology for converting 2D x-ray images into 3D models, in conjunction with the annual meeting of the American Association of Hip and Knee Surgeons ("AAHKS"), were very successful. The Annual Meeting, which brings together leading orthopedic professionals, was held in Dallas, USA on 4-5 November 2022.Ortoma announced on October 31, 2022, that the Company would present a proof-of-concept solution for converting 2D x-ray images into 3D models built on the Company's

Notice of Extraordinary General Meeting in Swedish Stirling AB (publ)

The shareholders of Swedish Stirling AB (publ), Reg. No 556760-6602, are hereby invited to the Extraordinary General Meeting on 28 November 2022.The Board of Directors has decided that the Extraordinary General Meeting (the “EGM”) is to be held only through postal voting in accordance with temporary legislation. This means that the EGM will be conducted without the physical presence of shareholders, representatives or external parties and that shareholders will only be able to exercise their voting rights by postal voting in advance of the EGM in the manner described below. A. RIGHT TO

Interim Report Q3 – July – September, 2022 Redsense Medical AB (publ)

Focus ahead as US purchasing patterns burden Q3 July – September 2022 · Net sales amounted to kSEK 1,023 (3,566), a decrease of 71.3 percent. · Operating loss, EBIT amounted to kSEK 5,857 (2,852). · Result after tax amounted to kSEK -2,372 (-2,547). · Earnings per share was SEK -0.23 (-0.18) before and after dilution. January – September 2022 · Net sales amounted to kSEK 6,077 (6,008), an increase of 1 percent. · Operating loss, EBIT amounted to kSEK 10,506 (9,218). · Result after tax amounted to kSEK -6,205 (-6,937). · Earnings per share was SEK -0.50 (-0.

Boston Medical Center selects Sectra Enterprise Imaging for radiology, breast imaging and orthopaedics

Linköping, Sweden and Shelton, CT – November 9, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a contract with Boston Medical Center (BMC) for enterprise imaging as a subscription (Sectra One). The solution has the capability of supporting all current and future imaging needs through a common platform with advanced diagnostic and clinical tools, integrated with Epic.The contract, signed in September 2022, includes modules for radiology, breast imaging, and orthopaedics. Additionally, the Sectra VNA will archive all

Interim Report Third Quarter 2022

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2022 – 30.09.2022. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: Q3 2022 marked several milestones that will help us grow sales and our leadership role during 2023 and onwards. We entered two new countries with medical cannabis oil products, we had another product

There are no items matching the current filter
There are no more items matching the current filter
Back to top